Uptake of various forms and amounts of vitamin B12 (Part I-IMPROVIT)

Department of Biotechnology New Delhi India1 个研究点分布在 1 个国家目标入组 61 人开始时间: 2015年10月21日最近更新: 2017年1月16日

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 61
试验地点: 1
主要终点: Difference in uptake

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The rise in plasma holotranscobalamin is 2-3 folds higher in cyanocobalamin supplemented than hydroxocobalamin supplemented participants. Detail analysis is being carried out .

研究设计

研究类型: Observational

入排标准

年龄范围: 18.00 Year(s) 至 50.00 Year(s)（—）
性别: All

入选标准

•Vegetarians with low plasma vitamin B12 in Indian participants and with normal vitamin B12 status Danish participants.

排除标准

•Non vegetarians, cancer and the participants consuming vitamin B12 pills and the drugs known to influence vitamin B12 absorption.

结局指标

主要结局

Difference in uptake

时间窗: Baseline and two days after supplementation and then crossover

次要结局

Metabolic effects of both cyano and hydroxo coabalamin in vegetarian Indians(Holotranscoabalamin levels before and after supplementation and crossover)

研究者

发起方

Department of Biotechnology New Delhi India

申办方类型

Government funding agency

研究点 (1)

Loading locations...

相似试验

尚未招募

1 期

Improving vitamin B12 status of Indians.

CTRI/2019/08/021001BBSRC

已完成

不适用

TRIM: Danish Form and Dose Study on Vitamin B12Healthy

NCT02832726University of Aarhus45

已完成

不适用

Plasma Holotranscobalamin as Compared to Plasma Cobalamins for Assessment of Vitamin B12 AbsorptionVitamin B12 Absorption

NCT00306358University of Aarhus78

已完成

不适用

Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With MetforminDiabetes Mellitus Type 2

NCT02111967University Hospital, Basel, Switzerland50

已完成

4 期

Megadose of Hydroxocobalamin for the Treatment of Pernicious AnemiaMegaloblastic Anemia NosPernicious Anemia

NCT03372447Hospital Universitario Dr. Jose E. Gonzalez13